Dengue vaccine 'Qdenga' to launch in India next year
Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the 'Make-in-India' initiative. The company will employ a tiered pricing model to enhance accessibility and is currently undergoing regulatory processes, with expectations of licensing in 2026.
Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the 'Make-in-India' initiative. The company will employ a tiered pricing model to enhance accessibility and is currently undergoing regulatory processes, with expectations of licensing in 2026.
